secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lipocine Inc. (LPCN)
CIK:        0001535955
Form:       8-K
Filed at:   2026-06-12T20:05:55+00:00
Accession:  0001493152-26-028429
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipocine hosts KOL event for postpartum depression drug LPCN 1154
-----------------------------------------------------------------

- Virtual key opinion leader event held on June 12, 2026.
- Event highlighted unmet needs in postpartum depression and clinical profile of LPCN 1154.
- Presentation slides available on corporate website; no new clinical data disclosed in the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1535955/000149315226028429/0001493152-26-028429-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1535955/000149315226028429/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028429

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer